| Brittani Kay Dingess, DO | |
|
100 Ashland Dr, Ste 102, Ashland, KY 41101 | |
| (606) 836-0919 | |
| Not Available |
| Full Name | Brittani Kay Dingess |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 100 Ashland Dr, Ashland, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528405875 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | TP208 (Kentucky) | Secondary |
| 208000000X | Pediatrics | 04014 (Kentucky) | Primary |
| Entity Name | Ashland Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659328250 PECOS PAC ID: 7719882521 Enrollment ID: O20031204000877 |
News Archive
An international research team has found a way to improve the anti-cancer effect of a new medicine class called 'Smac mimetics'.
Takeda Pharmaceutical Company Limited today announced that the company will present data from its expanding oncology pipeline and established product portfolio at two upcoming virtual scientific congresses: the 56th Annual Meeting of the American Society of Clinical Oncology, May 29-31 and the 25th Virtual Congress of the European Hematology Association, June 11-14.
In a move that highlights the strength of public-private collaboration in tackling international health challenges, the Maryland-based company Sanaria Inc., with support from the PATH Malaria Vaccine Initiative (MVI), has initiated a Phase 1 clinical trial - the first tests in adult volunteers - of its unique malaria vaccine candidate. Unlike other malaria vaccine candidates, Sanaria's approach deploys a weakened form of the whole malaria parasite harvested from irradiated mosquitoes instead of small portions of the parasite.
The three-part study includes the first large randomised control trial of mindfulness training compared with 'teaching as usual' in 76 schools, which will involve nearly six thousand students aged 11 to 14. Other parts of the study are a programme of experimental research to establish whether and how mindfulness improves the mental resilience of teenagers, and an evaluation of the most effective way to train teachers to deliver mindfulness classes to students.
A unique study which has followed 300 young people from age five since 2000, has received backing for a third phase which will see it become the first study of its kind in the world to track the same group from childhood to adulthood.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittani Kay Dingess, DO Po Box 1595, Ashland, KY 41105-1595 Ph: (606) 408-6200 | Brittani Kay Dingess, DO 100 Ashland Dr, Ste 102, Ashland, KY 41101 Ph: (606) 836-0919 |
News Archive
An international research team has found a way to improve the anti-cancer effect of a new medicine class called 'Smac mimetics'.
Takeda Pharmaceutical Company Limited today announced that the company will present data from its expanding oncology pipeline and established product portfolio at two upcoming virtual scientific congresses: the 56th Annual Meeting of the American Society of Clinical Oncology, May 29-31 and the 25th Virtual Congress of the European Hematology Association, June 11-14.
In a move that highlights the strength of public-private collaboration in tackling international health challenges, the Maryland-based company Sanaria Inc., with support from the PATH Malaria Vaccine Initiative (MVI), has initiated a Phase 1 clinical trial - the first tests in adult volunteers - of its unique malaria vaccine candidate. Unlike other malaria vaccine candidates, Sanaria's approach deploys a weakened form of the whole malaria parasite harvested from irradiated mosquitoes instead of small portions of the parasite.
The three-part study includes the first large randomised control trial of mindfulness training compared with 'teaching as usual' in 76 schools, which will involve nearly six thousand students aged 11 to 14. Other parts of the study are a programme of experimental research to establish whether and how mindfulness improves the mental resilience of teenagers, and an evaluation of the most effective way to train teachers to deliver mindfulness classes to students.
A unique study which has followed 300 young people from age five since 2000, has received backing for a third phase which will see it become the first study of its kind in the world to track the same group from childhood to adulthood.
› Verified 5 days ago
Ishmael Worth Stevens Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 13th St, Ashland, KY 41101 Phone: 606-329-0204 Fax: 606-324-7770 | |
John Roger Potter, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 700 13th St, Ashland, KY 41101 Phone: 606-329-0204 Fax: 606-324-7770 | |
Dr. Monica Evette Cline, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10650 Us Route 60, Ashland, KY 41102 Phone: 606-408-7337 Fax: 606-408-7798 | |
Ashok K Khanna, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12470 Us Route 60, Ashland, KY 41102 Phone: 606-408-6300 Fax: 606-408-6647 | |
Jason Ford, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2910 Carter Ave, Ashland, KY 41101 Phone: 606-324-7337 Fax: 606-326-9596 | |
Dr. Courtney Elizabeth De Jesso, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 |